Cold News and Research

RSS

Cancer-fighting antibodies may trigger autoimmune brain disorders

Consider two seemingly unrelated medical puzzles. First: Every day, our bodies produce hundreds of billions of new cells, many of which are mutated.

25 Mar 2026

New pathway enhances brown fat thermogenesis and metabolic health

Researchers have determined how a key protein activates brown fat by expanding blood vessels and nerves in the heat-generating tissue.

25 Mar 2026

How behavior and biology combine to drive addiction

Genomic analyses reveal that addiction risk is influenced by both shared behavioral traits and specific biological factors, informing prevention and treatment.

24 Mar 2026

Extreme cold linked to sharp rise in heart-related deaths

On the heels of one of the coldest winters in memory for large swaths of the country, new research highlights an often overlooked cost of cold weather: months with lower temperatures see significantly greater rates of death from heart attacks, strokes and coronary artery disease than milder months.

24 Mar 2026

Blocking a single protein could make hidden HPV-positive tumors vulnerable to treatment

A team of scientists at Henry Ford Health + Michigan State University Health Sciences have uncovered a mechanism that allows certain head and neck cancers to hide from the immune system, a discovery that could change how some of the most treatment resistant tumors are approached.

18 Mar 2026

Gut-derived blood markers may help predict who develops coronary heart disease

Researchers used five prospective cohorts from the US and China to identify circulating gut microbiota-related metabolites linked to future coronary heart disease, then tested the findings through discovery, in silico validation, and targeted quantitative validation. The study ultimately highlighted nine metabolites associated with incident CHD, supporting a potential role for microbial metabolism in heart disease risk while not proving causation

18 Mar 2026

New nanoparticle therapy overcomes T cell exhaustion in solid tumors

Engineers at the University of Pennsylvania have developed a new type of lipid nanoparticle (LNP) that could one day serve as a universal immunotherapy for cancers that form solid tumors, including common variants such as cancers of the breast, liver and colon.

18 Mar 2026

One-dose oral treatment may be the simplest weapon against sleeping sickness

Sleeping sickness has been killing people across Africa for generations. A disease with no vaccine, spread by the bite of a tsetse fly, it was once treated with injections of an arsenic derivative, a cure that could be as dangerous as the illness itself.

17 Mar 2026

Protein MIIP suppresses colorectal cancer by regulating immune cell signaling

Colorectal cancer remains one of the leading causes of cancer-related mortality worldwide, largely due to metastasis and limited responses to immunotherapy in most patients.

16 Mar 2026

New aeroponic technology delivers essential Vitamin B12 through salad crops

A pioneering research-industry partnership has used advances in indoor farming technology to grow pea shoots fortified with Vitamin B12, opening an exciting route to market for farmers and addressing a major public health need.

13 Mar 2026

Disrupting protein production in tumors triggers potent immune responses

A new study led by Pierre Close's team (GIGA, Laboratory of Cancer Signaling, and WELRI Investigator) reveals how subtly disrupting the way tumors produce their proteins can trigger a potent antitumor immune response.

11 Mar 2026

DNA origami vaccine platform shows promise against multiple infectious viruses

The COVID-19 pandemic brought messenger RNA (mRNA) vaccines to the forefront of global health care. After their clinical trial stages, the first COVID-19 mRNA vaccine was administered on 8 December 2020 and mathematical models suggest that mRNA vaccines prevented at least 14.4 million deaths from COVID-19 in the first year alone.

11 Mar 2026

The winter dare that leaves kids’ tongues stuck to metal

Insights from historical reports on tundra tongue incidents reveal risks to children and emphasize the need for education and effective first-aid strategies.

10 Mar 2026

Scientists identify ANKIB1 as key regulator of innate immune signaling

Innate immune sensors – known as pattern recognition receptors (PRRs) – detect specific molecular components of bacterial or viral intruders.

6 Mar 2026

Minimally invasive ablation effective for early-stage kidney cancers

A large national study in Denmark following nearly 1,900 patients over almost a decade found that a minimally invasive procedure called ablation is as effective as surgery for treating small kidney cancers, with faster recovery and fewer complications. Results of the study were published today in Radiology, a journal of the Radiological Society of North America (RSNA).

3 Mar 2026

Research suggests new therapeutic targets for broad-spectrum antiviral drugs

Coronaviruses not only use the machinery of the human cells they infect: they modify it to achieve optimal conditions to produce viral proteins and thus spread more quickly. This is the main conclusion of a study by Pompeu Fabra University published in Nature Communications.

3 Mar 2026

Scientists put forward a new theory of brain development

Your brain begins as a single cell. When all is said and done, it will house an incredibly complex and powerful network of some 170 billion cells.

2 Mar 2026

Corneal nerve function declines with age in aniridia patients

Congenital aniridia is a rare disease caused, in most cases, by mutations in the PAX6 gene, which is essential for the development of ocular structures.

27 Feb 2026

Combination therapy may help overcome barrier in early-stage prostate cancer treatment

A multi-institutional study led by Mayo Clinic and published in Cell Reports Medicine reports that pairing a next-generation immunotherapy with standard hormone therapy before surgery may help overcome a long-standing barrier in early-stage prostate cancer treatment.

26 Feb 2026